Hood River Capital Management LLC Has $20.17 Million Position in Tabula Rasa Healthcare Inc. (TRHC)

Hood River Capital Management LLC lowered its stake in shares of Tabula Rasa Healthcare Inc. (NASDAQ:TRHC) by 8.6% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 754,259 shares of the company’s stock after selling 70,966 shares during the period. Tabula Rasa Healthcare accounts for approximately 1.3% of Hood River Capital Management LLC’s portfolio, making the stock its 29th biggest holding. Hood River Capital Management LLC owned 4.23% of Tabula Rasa Healthcare worth $20,169,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently bought and sold shares of the company. TIAA CREF Investment Management LLC boosted its stake in shares of Tabula Rasa Healthcare by 108.5% during the first quarter. TIAA CREF Investment Management LLC now owns 8,131 shares of the company’s stock valued at $110,000 after acquiring an additional 4,232 shares during the last quarter. Financial Consulate Inc. acquired a new stake in shares of Tabula Rasa Healthcare during the third quarter valued at $222,000. Rhumbline Advisers acquired a new stake in shares of Tabula Rasa Healthcare during the third quarter valued at $253,000. New York State Common Retirement Fund boosted its stake in shares of Tabula Rasa Healthcare by 257.0% during the second quarter. New York State Common Retirement Fund now owns 10,000 shares of the company’s stock valued at $151,000 after acquiring an additional 7,199 shares during the last quarter. Finally, Bank of New York Mellon Corp acquired a new stake in shares of Tabula Rasa Healthcare during the first quarter valued at $178,000. 25.80% of the stock is currently owned by institutional investors and hedge funds.

Shares of Tabula Rasa Healthcare Inc. (TRHC) traded down $0.54 during trading hours on Thursday, reaching $31.28. The company’s stock had a trading volume of 152,400 shares, compared to its average volume of 90,589. The company has a current ratio of 0.73, a quick ratio of 0.66 and a debt-to-equity ratio of 0.47. Tabula Rasa Healthcare Inc. has a 12-month low of $10.51 and a 12-month high of $33.25.

Tabula Rasa Healthcare (NASDAQ:TRHC) last issued its quarterly earnings results on Monday, November 6th. The company reported $0.08 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.06 by $0.02. Tabula Rasa Healthcare had a negative return on equity of 5.58% and a negative net margin of 2.27%. The firm had revenue of $33.27 million for the quarter, compared to analyst estimates of $31.76 million. During the same period last year, the company earned $0.06 EPS. The firm’s quarterly revenue was up 37.6% on a year-over-year basis. sell-side analysts expect that Tabula Rasa Healthcare Inc. will post 0.05 earnings per share for the current year.

In other Tabula Rasa Healthcare news, insider Orsula V. Knowlton sold 8,000 shares of the firm’s stock in a transaction dated Wednesday, October 18th. The stock was sold at an average price of $26.68, for a total value of $213,440.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 45.80% of the stock is currently owned by company insiders.

A number of research firms recently commented on TRHC. Zacks Investment Research lowered Tabula Rasa Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Friday, November 10th. Piper Jaffray Companies reaffirmed an “overweight” rating and set a $35.00 price objective on shares of Tabula Rasa Healthcare in a research note on Tuesday, November 7th. They noted that the move was a valuation call. First Analysis began coverage on Tabula Rasa Healthcare in a research note on Wednesday, November 1st. They set an “overweight” rating and a $41.00 price objective on the stock. Wells Fargo & Company increased their price objective on Tabula Rasa Healthcare from $21.00 to $27.00 and gave the company a “market perform” rating in a research note on Thursday, October 19th. Finally, Robert W. Baird reaffirmed an “outperform” rating and set a $30.00 price objective (up previously from $22.00) on shares of Tabula Rasa Healthcare in a research note on Tuesday, October 17th. Three research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $28.25.

COPYRIGHT VIOLATION WARNING: “Hood River Capital Management LLC Has $20.17 Million Position in Tabula Rasa Healthcare Inc. (TRHC)” was reported by Markets Daily and is the property of of Markets Daily. If you are accessing this news story on another publication, it was illegally copied and reposted in violation of international trademark & copyright laws. The original version of this news story can be read at https://www.themarketsdaily.com/2017/11/16/hood-river-capital-management-llc-has-20-17-million-position-in-tabula-rasa-healthcare-inc-trhc.html.

Tabula Rasa Healthcare Profile

Tabula Rasa HealthCare, Inc (Tabula Rasa), formerly CareKinesis, Inc, is a provider of patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations and manage risk. The Company delivers its solutions through a suite of technology-enabled products and services for medication risk management, which includes bundled prescription fulfillment and adherence packaging services for client populations with complex prescription needs.

Institutional Ownership by Quarter for Tabula Rasa Healthcare (NASDAQ:TRHC)

Receive News & Ratings for Tabula Rasa Healthcare Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa Healthcare Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply